Abstract
The medical records of 39 patients withAcinetobacter bacteremia identified in the period between 1985 and 1995 were reviewed. In 24 cases (62%) the bacteremia was considered to have been clinically significant. Most of the infections (79%) were nosocomial, and the majority of these were acquired in an intensive care unit. Ten (42%) patients developed septic shock complicating the bacteremia and 13 (54%) died. In most of these cases (85%),Acinetobacter bacteremia was thought to have caused or contributed to death. The following variables were associated with a greater risk of mortality: age > 65 years (OR = 16; p=0.01); development of septic shock (OR = 22; p=0.004); and the presence of coagulopathy (OR =20; p=0.03).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bergogne-Bérézin E, Towner KJ:Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clinical Microbiology Reviews 1996, 9: 148–165.
Retailliau HF, Hightower AW, Dixon RE, Allen JR:Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern. Journal of Infectious Diseases 1979, 139: 371–375.
Smego RA: Endemic nosocomialAcinetobacter calcoaceticus bacteremia: clinical significance, treatment, and prognosis. Archives of Internal Medicine 1985, 145: 2174–2179.
Tilley PAG, Roberts FJ: Bacteremia withAcinetobacter species: risk factors and prognosis in different clinical settings. Clinical Infectious Diseases 1992, 18: 896–900.
Seifert H, Strate A, Pulverer G: Nosocomial bacteremia due toAcinetobacter baumannii: clinical features, epidemiology, and predictors of mortality. Medicine 1995, 74: 340–349.
Cisneros JM, Reyes MJ, Pachón J, Becerril B, Caballero FJ, García-Garmendía JL, Ortiz C, Cobacho AR: Bacteremia due toAcinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clinical Infectious Diseases 1996, 22: 1026–1032.
von Graevenitz A:Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative gram-negative bacteria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RD (ed): Manual of Clinical Microbiology, Washington, DC, 1995, p. 520–532.
National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. NCCLS, Wayne, PA, 1997.
Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. American Journal of Infection Control 1988, 16: 128–140.
McCabe WR, Jackson GG: Gram-negative bacteremia: etiology and ecology. Archives of Internal Medicine 1962, 110: 847–855.
Crombach WHJ, Dijkshoorn L, van Noort-Klaassen M, Niessen J, van Knippenberg-Gordebeke G: Control of an epidemic spread of a multi-resistant strain ofAcinetobacter calcoaceticus in a hospital. Intensive Care Medicine 1989, 15: 166–170.
Timsit J-F, Garrait V, Misset B, Goldstein FW, Renaud B, Carlet J: The digestive tract is a major site forAcinetobacter baumannii colonization in intensive care unit patients. Journal of Infectious Diseases 1993, 168: 1336–1337.
Seifert H, Strate A, Schulze A, Pulverer G: Bacteremia due toAcinetobacter species other thanAcinetobacter baumannii. Infection 1994, 22: 379–385.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Poutanen, S.M., Louie, M. & Simor, A.E. Risk factors, clinical features and outcome ofAcinetobacter bacteremia in adults. Eur. J. Clin. Microbiol. Infect. Dis. 16, 737–740 (1997). https://doi.org/10.1007/BF01709254
Issue Date:
DOI: https://doi.org/10.1007/BF01709254